Lung aeration and Lung perfusion Before and After Electrocardioversion

Lung aeration and Lung perfusion Before and After Electrocardioversion - Lung aeration and lung perfusion changes by Electrocardioversion

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37853

Enrollment

Registered

2012-05-15

Start date

2012-05-25

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atelectasis and lung perfusion

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Hemodynamically stable patients coming for electrocardioversion because of atrial fibrillation

Exclusion criteria

Exclusion criteria: o Age

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the change in regional lung aeration before and after ECV, assessed by EIT.	—

Secondary

Measure	Time frame
Secondary study endpoint is the change in regional lung perfusion before and after ECV, assessed by EIT.	—

Countries

Netherlands

Outcome results